Topiramate and the vision: a systematic review
Background and purpose Topiramate (TPM) is a sulfa-derivative monosaccharide that is
used mainly for treating epilepsy and preventing migraine. Within the gamut of side effects …
used mainly for treating epilepsy and preventing migraine. Within the gamut of side effects …
Drug-induced uveitis
RS Moorthy, MS Moorthy… - Current opinion in …, 2018 - journals.lww.com
The ever-broadening scope of pharmaceuticals now available to treat previously untreatable
conditions, such as advanced metastatic cutaneous melanoma, have resulted in unintended …
conditions, such as advanced metastatic cutaneous melanoma, have resulted in unintended …
[HTML][HTML] Eye disorders associated with newer antiepileptic drugs: a real-world disproportionality analysis of FDA adverse event reporting system
W Hu, L Chen, H Li, J Liu - Seizure, 2022 - Elsevier
Background Newer antiepileptic drugs such as levetiracetam, lacosamide, topiramate,
gabapentin, oxcarbazepine, lamotrigine, and zonisamide are prescribed by physicians for …
gabapentin, oxcarbazepine, lamotrigine, and zonisamide are prescribed by physicians for …
Psychotropic drug-induced glaucoma: a practical guide to diagnosis and management
NS Jain, CW Ruan, SR Dhanji, RJ Symes - CNS drugs, 2021 - Springer
This article provides a practical review of the diagnosis and management of angle closure
induced by psychotropic agents, including tricyclic antidepressants, antipsychotics and …
induced by psychotropic agents, including tricyclic antidepressants, antipsychotics and …
Ocular toxicity from systemically administered xenobiotics
MR Gokulgandhi, AD Vadlapudi… - Expert opinion on drug …, 2012 - Taylor & Francis
Introduction: The eye is considered as the most privileged organ because of the blood–
ocular barrier that acts as a barrier to systemically administered xenobiotics. However, there …
ocular barrier that acts as a barrier to systemically administered xenobiotics. However, there …
[HTML][HTML] The ophthalmic side effects of topiramate: a review
M Mechrgui, S Kanani - Cureus, 2022 - ncbi.nlm.nih.gov
Topiramate (TPM) is a sulfonamide drug with multiple modes of action. It inhibits carbonic
anhydrase, blocks sodium channels, enhances potassium channels, and stimulates …
anhydrase, blocks sodium channels, enhances potassium channels, and stimulates …
Topiramate-induced acute angle closure with severe panuveitis: A challenging case report
P Mahendradas, S Parab, R Sasikumar… - Indian Journal of …, 2018 - journals.lww.com
A 36-year-old female presented with the complaints of pain, photophobia, redness, and
sudden diminution of vision in both the eyes following topiramate for migraine treatment. On …
sudden diminution of vision in both the eyes following topiramate for migraine treatment. On …
Anterior uveitis
C Martin, P Rochat, E Crowell - The Rose and Mackay Textbook of …, 2024 - Elsevier
Uveitis is defined as inflammation of the uvea, or pigmented layer of the eye, which includes
the iris, ciliary body, and choroid.“Anterior uveitis” specifically describes the inflammation of …
the iris, ciliary body, and choroid.“Anterior uveitis” specifically describes the inflammation of …
Topiramate-induced angle-closure glaucoma: cross-sensitivity with other sulphonamide derivatives causing anterior uveitis
S Kamal, U Yadava, S Kumar, R Goel - International ophthalmology, 2014 - Springer
Topiramate is a recognized cause of drug-induced acute angle-closure glaucoma. We
describe a case presenting with bilateral acute angle-closure glaucoma caused by …
describe a case presenting with bilateral acute angle-closure glaucoma caused by …
Drug-induced inflammation in patients on TNFα inhibitors
ET Cunningham Jr, S Pasadhika… - Ocular Immunology …, 2012 - Taylor & Francis
1California Pacific Medical Center, San Francisco, and The Department of Ophthalmology,
Stanford University School of Medicine, Stanford, California, USA, 2Department of …
Stanford University School of Medicine, Stanford, California, USA, 2Department of …